Exploring structural covariance networks of gray matter in Parkinson’s disease
Objective: To investigate whether structural covariance networks (SCNs) can be used to detect disease-specific patterns of gray matter atrophy in Parkinson's disease (PD) and secondly,…Outpatient management of Parkinson’s disease: A review of medication changes made to address both motor and non-motor symptoms
Objective: To identify reasons for medication changes at outpatient movement disorder clinics and determine outcome of these changes at next clinic visit. Background: Parkinson's disease…Non motor symptoms of Parkinson’s disease: Prevalence and impact on quality of life
Objective: To highlight the frequency of non motor symptoms in patients with Parkinson's disease and to evaluate their impact on quality of life. Background: Parkinson's…Speech evaluation in Parkinson’s disease using a transcribed version of the Frenchay dysarthria assessment
Objective: To assess the usefulness and metric properties of a transcribed version of the Frenchay Dysarthria Assessment 2 (FDA-2) for speech evaluation in a cohort…Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease
Objective: To explore the relation between the non-motor symptoms (NMS) of PD and the involvement of brainstem through studying VEMPs. Background: Degeneration of several brainstem…Pallidal versus subthalamic stimulation for PD: Beyond the motor effects
Objective: To evaluate the effects of Deep Brain Stimulation(DBS) on non motor symptoms(NMS) in Parkinson's disease(PD) and compare the efficacy of pallidal(GPi) versus subthalamic(STN) stimulation.…Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota
Objective: To assess distal functional gastrointestinal (GI) symptoms and their connection to fecal microbiota (FM) in Parkinson (PD) patients. Background: The majority of PD patients…Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease
Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…Behavioral and neuroimaging effects of LSVT-BIG and conventional physiotherapy in Parkinson’s disease
Objective: To evaluate (1) the changes of non-motor symptoms such as depression, sleep disorders, pain and cognitive deficits in PD by practicing LSVT BIG therapy…Clinical profile and outcome of hospitalized patients with Parkinson’s disease
Objective: In this study we explored the cause of hospitalization, clinical course and outcome among Parkinson's disease (PD) patients. Background: Patients with PD are frequently…
- « Previous Page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- …
- 51
- Next Page »